henhaobio
Sign in

Genome MedicineGenomicsPeer-reviewed journal article

Multiple approaches for massively parallel sequencing of HCoV-19 (SARS-CoV-2) genomes directly from clinical samples

Minfeng XiaoiD, Xiaoqing LiuiD, Jingkai JiiD, Min LiiD, Jiandong LiiD, Lin YangiD, Wanying Sun, Peidi Ren, Guifang YangiD, Jincun ZhaoiD, Tianzhu Liang, Huahui ReniD, Tian CheniD, Huanzi ZhongiD, Wenchen SongiD, Yanqun WangiD, Ziqing DengiD, Yanping ZhaoiD, Zhihua OuiD, Daxi WangiD, Jielun Cai, Xinyi Cheng, Taiqing Feng, Honglong WuiD, Yanping Gong, , Junhua LiiD

PDFDOIPreprint

Abstract

COVID-19 has caused a major epidemic worldwide, however, much is yet to be known about the epidemiology and evolution of the virus. One reason is that the challenges underneath sequencing HCoV-19 directly from clinical samples have not been completely tackled. Here we illustrate the application of amplicon and hybrid capture (capture)-based sequencing, as well as ultra-high-throughput metatranscriptomic (meta) sequencing in retrieving complete genomes, inter-individual and intra-individual variations of HCoV-19 from clinical samples covering a range of sample types and viral load. We also examine and compare the bias, sensitivity, accuracy, and other characteristics of these approaches in a comprehensive manner. This is, to date, the first work systematically implements amplicon and capture approaches in sequencing HCoV-19, as well as the first comparative study across methods. Our work offers practical solutions for genome sequencing and analyses of HCoV-19 and other emerging viruses.

Citations
141
FWCI
3.60
Field percentile
top 4%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISDoddapaneni '20Doddapaneni '21Resende '20Bhoyar '21Chen '20Davina-Nune '23
69% semantic matchMicrobiology
H. V. Doddapaneni, S. J. Cregeen, R. Sucgang+18 more·bioRxiv·Jul 27, 2020